Search | TVST | ARVO Journals

Showing 1 – 20 of 28

SORT: Best Match Most Recent Oldest

VIEW: Basic | Expanded

ARVO Annual Meeting Abstract June 2024

Greater reduction in pigment epithelial detachment size in TENAYA/LUCERNE with faricimab 6.0 mg vs aflibercept 2.0 mg during head-to-head dosing in patients with nAMD

Nikolas London; Arshad M. Khanani; Timothy Y Y Lai; Jennifer I Lim; Aachal Kotecha; Philippe Margaron; Shriji Patel; Audrey Souverain; Jeffrey R Willis; Ming Yang

Invest. Ophthalmol. Vis. Sci.. 2024; 65(7):5690.

ARVO Annual Meeting Abstract June 2024

Efficacy, safety, and durability of faricimab in macular edema due to retinal vein occlusion: 72-week results from the BALATON and COMINO trials

Faruque Ghanchi; Francis Abreu; Pablo Arrisi; Aachal Kotecha; Ying Liu; Liliana P Paris; Anne-Cecile Retiere; Jeffrey R Willis

Invest. Ophthalmol. Vis. Sci.. 2024; 65(7):3124.

ARVO Annual Meeting Abstract June 2024

Impact of Early Intraretinal Fluid Reduction on One-Year Outcomes in Diabetic Macular Edema

Yiyi Wang; Derrek Hibar; Andreas Maunz; Huanxiang Lu; Thomas Albrecht; Kara Gibson; Jeffrey Ryuta Willis; Dolly Shuo-Teh Chang; Katie M Litts

Invest. Ophthalmol. Vis. Sci.. 2024; 65(7):4886.

Clinical and Epidemiologic Research May 2024

Intraretinal Hyper-Reflective Foci Are Almost Universally Present and Co-Localize With Intraretinal Fluid in Diabetic Macular Edema

PDF

Esther L. von Schulthess; Andreas Maunz; Usha Chakravarthy; Nancy Holekamp; Daniel Pauleikhoff; Katie Patel; Isabel Bachmeier; Siqing Yu; Yaniv Cohen; Mahnaz Parian Scherb; Ian L. Jones; Kara Gibson; Jeffrey R. Willis; Carl Glittenberg; Rishi P. Singh; Sascha Fauser
TAGS: diabetic macular edema, face, retina, severity of illness, spectral domain-optical coherence tomography, volume
Invest. Ophthalmol. Vis. Sci.. 2024; 65(5):26. https://doi.org/10.1167/iovs.65.5.26

Includes: Supplemental Content

ARVO Annual Meeting Abstract June 2023

Baseline characteristics associated with the first year treatment interval of intravitreal faricimab in diabetic macular edema (DME).

Parth Arvind Shah; Yannan Tang; Neala Rafijah; Zdenka Haskova; Jeffrey Ryuta Willis; Aachal Kotecha

Invest. Ophthalmol. Vis. Sci.. 2023; 64(8):2697.

Neuro-ophthalmology February 2023

Physical Activity in Functionally Monocular Persons in the United States, 2003–2006

PDF

Chandana Papudesu; Jeffrey Ryuta Willis; Pradeep Ramulu; Suzanne van Landingham
TAGS: physical activity, visual acuity, visual impairment, national health and nutrition examination survey, eye, obesity, vision
Trans. Vis. Sci. Tech.. 2023; 12(2):13. https://doi.org/10.1167/tvst.12.2.13

ARVO Annual Meeting Abstract June 2021

A multimodal deep learning (DL) model to predict visual acuity response in the CATT study

Jelena Novosel; Neha Anegondi; Jian Dai; Ebenezer Daniel; Glenn J Jaffe; Maureen G Maguire; Jeffrey R Willis

Invest. Ophthalmol. Vis. Sci.. 2021; 62(8):81.

ARVO Annual Meeting Abstract June 2021

Identification of choroidal neovascularization activity using deep learning

Xiaoyong Wang; Simon S. Gao; Michael Kawczynski; Neha Anegondi; Andreas Thalhammer; Thomas Bengtsson; Jeffrey R Willis; Jian Dai

Invest. Ophthalmol. Vis. Sci.. 2021; 62(8):2141.

ARVO Annual Meeting Abstract June 2021

Prediction of best-corrected visual acuity (BCVA) from color fundus photography (CFP) using deep learning (DL)

Michael Kawczynski; Neha Anegondi; Qi Yang; Jeffrey R Willis; Thomas Bengtsson; Simon S. Gao; Jian Dai

Invest. Ophthalmol. Vis. Sci.. 2021; 62(8):126.

ARVO Annual Meeting Abstract June 2021

Design and rationale of the YOSEMITE and RHINE trials: two phase 3 studies of faricimab in patients with diabetic macular edema

Nicole Eter; Jeffrey R Willis; Carlos Quezada Ruiz; Francis Abreu; Hugh Lin; David Silverman; Jane Ives; Karen Basu; Zdenka Haskova; Kemal Asik

Invest. Ophthalmol. Vis. Sci.. 2021; 62(8):1043.

ARVO Annual Meeting Abstract June 2021

Efficacy, durability, and safety of faricimab in diabetic macular edema (DME): one-year results from the phase 3 YOSEMITE and RHINE trials

John A Wells; Charles Clifton Wykoff; Jeffrey R Willis; Zdenka Haskova; Hugh Lin; David Silverman; Anthony P Adamis; Jane Ives; Francis Abreu; Karen Basu; Ramin Tadayoni

Invest. Ophthalmol. Vis. Sci.. 2021; 62(8):1037.

ARVO Annual Meeting Abstract June 2021

Dual angiopoietin-2 and VEGF-A inhibition with faricimab in neovascular age-related macular degeneration: phase 3 TENAYA and LUCERNE trial design

Robyn H Guymer; Carlos Quezada Ruiz; Jeffrey R Willis; David Silverman; Jane Ives; Karen Basu; Balakumar Swaminathan; Aachal Kotecha; Heather Boston; Hugh Lin

Invest. Ophthalmol. Vis. Sci.. 2021; 62(8):429.

ARVO Annual Meeting Abstract June 2021

Physical Activity in Functionally Monocular Patients in the United States, 2003-2006

Chandana Papudesu; Jeffrey Ryuta Willis; Pradeep Y Ramulu; Suzanne W van Landingham

Invest. Ophthalmol. Vis. Sci.. 2021; 62(8):3497.

Articles May 2021

Feasibility Study of a Multimodal, Cloud-Based, Diabetic Retinal Screening Program in a Workplace Environment

PDF

Jeffrey R. Willis; Ferhina S. Ali; Braelyn Argente; Amitha Domalpally; Jacqueline Gannon; Simon S. Gao; Shagun Grover; Purti Kanodia; Sparkle Russell-Puleri; Diana Sun; Cory Thrasher; Costas Tsougarakis; J. Jill Hopkins
TAGS: diabetes mellitus, feasibility studies, retinal screening, workplace, vision, self-report, transfer technique
Trans. Vis. Sci. Tech.. 2021; 10(6):20. https://doi.org/10.1167/tvst.10.6.20

Includes: Supplemental Content

Special Issue September 2020

Development of Deep Learning Models to Predict Best-Corrected Visual Acuity from Optical Coherence Tomography

PDF

Michael G. Kawczynski; Thomas Bengtsson; Jian Dai; J. Jill Hopkins; Simon S. Gao; Jeffrey R. Willis
TAGS: deep learning, eye, optical coherence tomography, visual acuity
Trans. Vis. Sci. Tech.. 2020; 9(2):51. https://doi.org/10.1167/tvst.9.2.51

Includes: Supplemental Content

ARVO Annual Meeting Abstract July 2019

Deep learning predicts OCT measures of diabetic macular thickening from color fundus photographs

Jeffrey Ryuta Willis; Filippo Arcadu; Fethallah Benmansour; Andreas Maunz; John Michon; Zdenka Haskova; Dana McClintock; Anthony P Adamis; Marco Prunotto

Invest. Ophthalmol. Vis. Sci.. 2019; 60(9):1538.

ARVO Annual Meeting Abstract July 2019

Deep learning algorithm for patient-level prediction of diabetic retinopathy (DR) response to vascular endothelial growth factor (VEGF) inhibition

Filippo Arcadu; Fethallah Benmansour; Andreas Maunz; Jeffrey Ryuta Willis; Marco Prunotto; Zdenka Haskova

Invest. Ophthalmol. Vis. Sci.. 2019; 60(9):2806.

ARVO Annual Meeting Abstract July 2019

Dual inhibition of Ang-2 and VEGF-A with faricimab in diabetic macular edema: Evidence for increased durability from the BOULEVARD phase 2 trial

Timothy Y Y Lai; Jayashree Sahni; Karen Basu; Stefan Scheidl; Jeffrey Ryuta Willis; Aaron Osborne

Invest. Ophthalmol. Vis. Sci.. 2019; 60(9):3860.

Retina March 2019

Deep Learning Predicts OCT Measures of Diabetic Macular Thickening From Color Fundus Photographs

PDF

Filippo Arcadu; Fethallah Benmansour; Andreas Maunz; John Michon; Zdenka Haskova; Dana McClintock; Anthony P. Adamis; Jeffrey R. Willis; Marco Prunotto
TAGS: color, deep learning, diabetes mellitus, diabetic macular edema, fundus photography, datasets
Invest. Ophthalmol. Vis. Sci.. 2019; 60(4):852-857. https://doi.org/10.1167/iovs.18-25634

Includes: Supplemental Content

ARVO Annual Meeting Abstract July 2018

Post-vitrectomy ocular hemorrhage among United States adults on oral antithrombotics

Ronald A Cantrell; Jeffrey Ryuta Willis; Susanna S Park; Yifeng Chia; Mariam Abouhossein; Giulio Barteselli

Invest. Ophthalmol. Vis. Sci.. 2018; 59(9):883.

1 2

Next 20 Results »

NARROW

Content Type

Journal

Article Type

Topics

Tags

Specify Date Range

Greater reduction in pigment epithelial detachment size in TENAYA/LUCERNE with faricimab 6.0 mg vs aflibercept 2.0 mg during head-to-head dosing in patients with nAMD

Efficacy, safety, and durability of faricimab in macular edema due to retinal vein occlusion: 72-week results from the BALATON and COMINO trials

Impact of Early Intraretinal Fluid Reduction on One-Year Outcomes in Diabetic Macular Edema

Intraretinal Hyper-Reflective Foci Are Almost Universally Present and Co-Localize With Intraretinal Fluid in Diabetic Macular Edema

Baseline characteristics associated with the first year treatment interval of intravitreal faricimab in diabetic macular edema (DME).

Physical Activity in Functionally Monocular Persons in the United States, 2003–2006

A multimodal deep learning (DL) model to predict visual acuity response in the CATT study

Identification of choroidal neovascularization activity using deep learning

Prediction of best-corrected visual acuity (BCVA) from color fundus photography (CFP) using deep learning (DL)

Design and rationale of the YOSEMITE and RHINE trials: two phase 3 studies of faricimab in patients with diabetic macular edema

Efficacy, durability, and safety of faricimab in diabetic macular edema (DME): one-year results from the phase 3 YOSEMITE and RHINE trials

Dual angiopoietin-2 and VEGF-A inhibition with faricimab in neovascular age-related macular degeneration: phase 3 TENAYA and LUCERNE trial design

Physical Activity in Functionally Monocular Patients in the United States, 2003-2006

Feasibility Study of a Multimodal, Cloud-Based, Diabetic Retinal Screening Program in a Workplace Environment

Development of Deep Learning Models to Predict Best-Corrected Visual Acuity from Optical Coherence Tomography

Deep learning predicts OCT measures of diabetic macular thickening from color fundus photographs

Deep learning algorithm for patient-level prediction of diabetic retinopathy (DR) response to vascular endothelial growth factor (VEGF) inhibition

Dual inhibition of Ang-2 and VEGF-A with faricimab in diabetic macular edema: Evidence for increased durability from the BOULEVARD phase 2 trial

Deep Learning Predicts OCT Measures of Diabetic Macular Thickening From Color Fundus Photographs

Post-vitrectomy ocular hemorrhage among United States adults on oral antithrombotics

To View More...

You must be signed into an individual account to use this feature.